Prologed lymphocytepenia after bendamustin and rituximab treatment in patients with iNHL and MCL

Maki Nemoto

Presentation information

Oral Session

Oral Session 2-10B Indolent Lymphoma: Prognostic Factors

Sat. Oct 12, 2019 10:10 AM - 11:10 AM No.10 (Tokyo International Forum, 4F G409)

Chair: Noriko Fukuhara (Tohoku University Hospital, Department of Hematology and Rheumatology)

[OS2-10B-4] Prologed lymphocytepenia after bendamustin and rituximab treatment in patients with iNHL and MCL

Maki Nemoto¹, Norihito Inoue², Keiich Azuma¹, Toshihiro Hama¹, Yasuhito Terui² (1.Japanise Foundation for Cancer Research, Tokyo, Japan, 2.Japanise Foundation for Cancer Research, Tokyo, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.